49:@0.895357:0.033217:0.916054:0.033217:0.916054:0.013052:0.895357:0.013052:0.010348:0.010348
HANDBOOK OF GENERAL MEDICINE VOL 1:@0.649278:0.972666:0.923020:0.972666:0.923020:0.958637:0.649278:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
TREATMENT AppROACHEs:@0.983817:0.243404:0.983817:0.056390:0.958557:0.056390:0.958557:0.243404:0.008796:-0.015759:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.114251:0.006043:0.014598:-0.134892:0.158618:-0.158618:0.000000:0.000000:0.000000:0.000000:0.242660:0.009202
TREATMENT AppROACHEs:@0.397039:0.033156:0.624383:0.033156:0.624383:0.013866:0.397039:0.013866:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
ability depends mostly on the sensitivity of assays used in :@0.076190:0.084931:0.485070:0.084931:0.485070:0.069149:0.076190:0.069149:0.010175:0.010160:0.002873:0.002873:0.002873:0.004974:0.007953:0.004309:0.010205:0.009676:0.010160:0.009676:0.009071:0.010205:0.005715:0.004309:0.014030:0.009752:0.005715:0.004974:0.002873:0.007953:0.004309:0.009752:0.009071:0.004309:0.004974:0.009071:0.009676:0.004324:0.005715:0.009676:0.009071:0.005715:0.002873:0.004974:0.002873:0.008225:0.002873:0.004974:0.007953:0.004309:0.009752:0.004596:0.004324:0.010175:0.005715:0.005715:0.010175:0.007953:0.005715:0.004309:0.009041:0.005715:0.009676:0.010205:0.004309:0.002873:0.009223:0.004188
various studies, the difference in definitions used for diag:@0.076190:0.099201:0.476059:0.099201:0.476059:0.083419:0.076190:0.083419:0.008225:0.010175:0.004400:0.002873:0.009752:0.009041:0.005715:0.003644:0.005715:0.004974:0.009041:0.010205:0.002873:0.009676:0.005715:0.004037:0.003644:0.004974:0.009071:0.009676:0.003644:0.010205:0.002873:0.004596:0.004596:0.009676:0.004400:0.009676:0.009071:0.009631:0.009676:0.003644:0.002873:0.009071:0.003644:0.010205:0.009676:0.003606:0.003606:0.009071:0.002873:0.004974:0.002873:0.009752:0.009071:0.005715:0.003644:0.009041:0.005715:0.009676:0.010205:0.003644:0.004596:0.009752:0.004400:0.003644:0.010205:0.002873:0.010175:0.010175
-:@0.475907:0.099201:0.480927:0.099201:0.480927:0.083419:0.475907:0.083419:0.005020
nosis, as well as the frequency of assessment of thyroid :@0.076190:0.113472:0.485191:0.113472:0.485191:0.097689:0.076190:0.097689:0.009071:0.009752:0.005715:0.002873:0.005715:0.004037:0.005730:0.010175:0.005715:0.005730:0.012413:0.009676:0.002873:0.002873:0.005730:0.010175:0.005715:0.005730:0.004974:0.009071:0.009676:0.005730:0.004596:0.004400:0.009676:0.010160:0.009041:0.009676:0.009071:0.009631:0.007953:0.005730:0.009752:0.004596:0.005730:0.010175:0.005715:0.005715:0.009676:0.005715:0.005715:0.014030:0.009676:0.009071:0.004974:0.005730:0.009752:0.004596:0.005730:0.004974:0.009071:0.007953:0.004400:0.009752:0.002873:0.010357:0.004188
function in different screening programmes.  The causes :@0.076190:0.127742:0.485154:0.127728:0.485154:0.111945:0.076190:0.111959:0.004596:0.009041:0.009071:0.009631:0.004974:0.002873:0.009752:0.009071:0.003765:0.002873:0.009071:0.003765:0.010205:0.002873:0.004596:0.004596:0.009676:0.004400:0.009676:0.009071:0.004974:0.003765:0.005715:0.009631:0.004400:0.009676:0.009676:0.009071:0.002873:0.009071:0.010024:0.003765:0.010160:0.004400:0.009752:0.010024:0.004400:0.010175:0.014030:0.014030:0.009676:0.005715:0.004188:0.009338:0.003765:0.006290:0.009071:0.009676:0.003765:0.009631:0.010175:0.009041:0.005715:0.009676:0.005866:0.681962
15:@0.388751:0.122429:0.398380:0.122429:0.398380:0.113275:0.388751:0.113275:0.004770:0.004858
of subclinical hyperthyroidism are the same as for overt :@0.076184:0.141998:0.485185:0.141998:0.485185:0.126215:0.076184:0.126215:0.009752:0.004596:0.005382:0.005715:0.009041:0.010160:0.009631:0.002873:0.002873:0.009071:0.002873:0.009631:0.010175:0.002873:0.005382:0.009071:0.007953:0.010160:0.009676:0.004400:0.004974:0.009071:0.007953:0.004400:0.009752:0.002873:0.010205:0.002873:0.005715:0.014030:0.005382:0.010175:0.004400:0.009676:0.005382:0.004974:0.009071:0.009676:0.005382:0.005715:0.010175:0.014030:0.009676:0.005382:0.010175:0.005715:0.005382:0.004596:0.009752:0.004400:0.005382:0.009752:0.008225:0.009676:0.004400:0.005125:0.004188
hyperthyroidism, but the most common cause is exog-:@0.076184:0.156268:0.480921:0.156268:0.480921:0.140485:0.076184:0.140485:0.009071:0.007953:0.010160:0.009676:0.004400:0.004974:0.009071:0.007953:0.004400:0.009752:0.002873:0.010205:0.002873:0.005715:0.014030:0.004037:0.006365:0.010160:0.009041:0.004974:0.006365:0.004974:0.009071:0.009676:0.006365:0.014030:0.009752:0.005715:0.004974:0.006365:0.009631:0.009752:0.014030:0.014030:0.009752:0.009071:0.006365:0.009631:0.010175:0.009041:0.005715:0.009676:0.006365:0.002873:0.005715:0.006365:0.009676:0.007106:0.009752:0.010024:0.005020
enous thyroid hormone replacement therapy.:@0.076184:0.170538:0.405507:0.170538:0.405507:0.154756:0.076184:0.154756:0.009676:0.009071:0.009752:0.009041:0.005715:0.004037:0.004974:0.009071:0.007953:0.004400:0.009752:0.002873:0.010205:0.004037:0.009071:0.009752:0.004400:0.014030:0.009752:0.009071:0.009676:0.004037:0.004400:0.009676:0.010160:0.002873:0.010175:0.009631:0.009676:0.014030:0.009676:0.009071:0.004974:0.004037:0.004974:0.009071:0.009676:0.004400:0.010175:0.010160:0.007953:0.004188
patients  are  usually asymptomatic, but many may :@0.090472:0.184808:0.485124:0.184808:0.485124:0.169026:0.090472:0.169026:0.008950:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188:0.004143:0.010326:0.004551:0.009827:0.004188:0.004143:0.009192:0.005866:0.009192:0.010326:0.003024:0.003024:0.008104:0.008346:0.010326:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.010326:0.005125:0.003024:0.009782:0.004188:0.008346:0.010311:0.009192:0.005125:0.008346:0.014182:0.010326:0.009223:0.008104:0.008346:0.014182:0.010326:0.008104:0.004188
present with subtle symptoms or signs of thyrotoxicosis. :@0.076184:0.199079:0.485139:0.199079:0.485139:0.183296:0.076184:0.183296:0.010311:0.004551:0.009827:0.005866:0.009827:0.009223:0.005125:0.005579:0.012564:0.003024:0.005125:0.009223:0.005594:0.005866:0.009192:0.010311:0.005125:0.003024:0.009827:0.005594:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.005594:0.009903:0.004551:0.005579:0.005866:0.003024:0.010175:0.009223:0.005866:0.005594:0.009903:0.004747:0.005579:0.005125:0.009223:0.008104:0.004551:0.009903:0.005125:0.009903:0.007257:0.003024:0.009782:0.009903:0.005866:0.003024:0.005866:0.004188:0.004188
The skeleton and cardiovascular system are, however, :@0.076184:0.213349:0.485139:0.213349:0.485139:0.197566:0.076184:0.197566:0.006441:0.009223:0.009827:0.005534:0.005866:0.007590:0.009827:0.003024:0.009827:0.005125:0.009903:0.009223:0.005549:0.010326:0.009223:0.010357:0.005549:0.009782:0.010326:0.004551:0.010357:0.003024:0.009903:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.005549:0.005866:0.008104:0.005866:0.005125:0.009827:0.014182:0.005549:0.010326:0.004551:0.009827:0.004188:0.005549:0.009223:0.009903:0.012564:0.009827:0.008376:0.009827:0.004551:0.004188:0.004188
adversely affected. subclinical hyperthyroidism is asso-:@0.076184:0.227619:0.480951:0.227619:0.480951:0.211836:0.076184:0.211836:0.010326:0.010357:0.008376:0.009827:0.004551:0.005866:0.009827:0.003024:0.008104:0.005216:0.010326:0.004747:0.004747:0.009827:0.009782:0.005125:0.009827:0.010357:0.004188:0.005216:0.007529:0.009192:0.010311:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.005231:0.009223:0.008104:0.010311:0.009827:0.004551:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.003024:0.005866:0.014182:0.005216:0.003024:0.005866:0.005216:0.010326:0.005866:0.005866:0.009903:0.005020
ciated with low bone-mineral density, especially at the :@0.076184:0.241889:0.485124:0.241889:0.485124:0.226106:0.076184:0.226106:0.009782:0.003024:0.010326:0.005125:0.009827:0.010357:0.004853:0.012564:0.003024:0.005125:0.009223:0.004853:0.003024:0.009903:0.012564:0.004853:0.010311:0.009903:0.009223:0.009827:0.005020:0.014182:0.003024:0.009223:0.009827:0.004551:0.010326:0.003024:0.004853:0.010357:0.009827:0.009223:0.005866:0.003024:0.005125:0.008104:0.004188:0.004853:0.009827:0.005866:0.010311:0.009827:0.009782:0.003024:0.010326:0.003024:0.003024:0.008104:0.004868:0.010326:0.005125:0.004853:0.005125:0.009223:0.009827:0.004188
femoral  neck  and  radius. Whether  these  changes  in-:@0.076184:0.256159:0.480921:0.256159:0.480921:0.240377:0.076184:0.240377:0.004747:0.009827:0.014182:0.009903:0.004551:0.010326:0.003024:0.004188:0.003024:0.009223:0.009827:0.009782:0.007590:0.004188:0.003024:0.010326:0.009223:0.010357:0.004188:0.003024:0.004551:0.010326:0.010357:0.003024:0.009192:0.005866:0.004188:0.007227:0.014514:0.009223:0.009827:0.005125:0.009223:0.009827:0.004551:0.004188:0.003024:0.005125:0.009223:0.009827:0.005866:0.009827:0.004188:0.003024:0.009782:0.009223:0.010326:0.009223:0.010175:0.009827:0.005866:0.004188:0.003024:0.003024:0.009223:0.005020
crease fracture rate is still a topic of debate.  patients :@0.076184:0.270429:0.485149:0.270382:0.485149:0.254600:0.076184:0.254647:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.005261:0.004747:0.004551:0.010326:0.009782:0.005125:0.009192:0.004551:0.009827:0.005261:0.004551:0.010326:0.005125:0.009827:0.005261:0.003024:0.005866:0.005277:0.005866:0.005125:0.003024:0.003024:0.003024:0.005277:0.010326:0.005277:0.005125:0.009903:0.010311:0.003024:0.009782:0.005277:0.009903:0.004747:0.005261:0.010357:0.009827:0.010311:0.010326:0.005125:0.009827:0.004188:0.009731:0.005277:0.008950:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.495158
13:@0.408498:0.265083:0.418214:0.265083:0.418214:0.255930:0.408498:0.255930:0.004858:0.004858
with subclinical hyperthyroidism have a higher risk of atri-:@0.076194:0.284652:0.480946:0.284652:0.480946:0.268870:0.076194:0.268870:0.012564:0.003024:0.005125:0.009223:0.003130:0.005866:0.009192:0.010311:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.003145:0.009223:0.008104:0.010311:0.009827:0.004551:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.003024:0.005866:0.014182:0.003130:0.009223:0.010326:0.008376:0.009827:0.003130:0.010326:0.003130:0.009223:0.003024:0.010175:0.009223:0.009827:0.004551:0.003115:0.004551:0.003024:0.005866:0.007590:0.003130:0.009903:0.004747:0.003130:0.010326:0.005125:0.004551:0.003024:0.005020
al fibrillation; they have increased left ventricular mass, :@0.076194:0.298923:0.485134:0.298923:0.485134:0.283140:0.076194:0.283140:0.010326:0.003024:0.005050:0.003681:0.003681:0.010311:0.004551:0.003024:0.003024:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.005050:0.005125:0.009223:0.009827:0.008104:0.005050:0.009223:0.010326:0.008376:0.009827:0.005050:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.005050:0.003024:0.009827:0.004747:0.005125:0.005050:0.008376:0.009827:0.009223:0.005125:0.004551:0.003024:0.009782:0.009192:0.003024:0.010326:0.004551:0.005050:0.014182:0.010326:0.005866:0.005866:0.004188:0.004188
increased ventricular contractility, and decreased ex-:@0.076194:0.313193:0.480961:0.313193:0.480961:0.297410:0.076194:0.297410:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.006395:0.008376:0.009827:0.009223:0.005125:0.004551:0.003024:0.009782:0.009192:0.003024:0.010326:0.004551:0.006395:0.009782:0.009903:0.009223:0.005125:0.004551:0.010326:0.009767:0.005125:0.003024:0.003024:0.003024:0.005125:0.008104:0.004188:0.006395:0.010326:0.009223:0.010357:0.006395:0.010357:0.009827:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.006380:0.009827:0.007257:0.005020
ercise tolerance.:@0.076194:0.327463:0.199036:0.327463:0.199036:0.311680:0.076194:0.311680:0.009827:0.004551:0.009782:0.003024:0.005866:0.009827:0.004188:0.005125:0.009903:0.003024:0.009827:0.004551:0.010326:0.009223:0.009782:0.009827:0.004188
The  natural  history  of  subclinical hyperthyroidism  is :@0.090482:0.341733:0.485119:0.341733:0.485119:0.325950:0.090482:0.325950:0.006441:0.009223:0.009827:0.004188:0.004460:0.009223:0.010326:0.005125:0.009192:0.004551:0.010326:0.003024:0.004188:0.004460:0.009223:0.003024:0.005866:0.005125:0.009903:0.004551:0.008104:0.004188:0.004460:0.009903:0.004747:0.004188:0.004460:0.005866:0.009192:0.010311:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.008663:0.009223:0.008104:0.010311:0.009827:0.004551:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.003024:0.005866:0.014182:0.004188:0.004460:0.003024:0.005866:0.004188
unclear,  and  the  progression  to  overt  hyperthyroidism :@0.076194:0.356003:0.485149:0.356003:0.485149:0.340221:0.076194:0.340221:0.009192:0.009223:0.009782:0.003024:0.009827:0.010326:0.004551:0.004188:0.004188:0.002343:0.010326:0.009223:0.010357:0.004188:0.002343:0.005125:0.009223:0.009827:0.004188:0.002343:0.010311:0.004551:0.009903:0.010175:0.004551:0.009827:0.005866:0.005866:0.003024:0.009903:0.009223:0.004188:0.002343:0.005125:0.009903:0.004188:0.002343:0.009903:0.008376:0.009827:0.004551:0.005125:0.004188:0.002343:0.009223:0.008104:0.010311:0.009827:0.004551:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.003024:0.005866:0.014182:0.004188
seems to be related to the degree of hyperthyroidism, :@0.076194:0.370273:0.485134:0.370273:0.485134:0.354491:0.076194:0.354491:0.005866:0.009827:0.009827:0.014182:0.005866:0.005382:0.005125:0.009903:0.005367:0.010311:0.009827:0.005382:0.004551:0.009827:0.003024:0.010326:0.005125:0.009827:0.010357:0.005382:0.005125:0.009903:0.005367:0.005125:0.009223:0.009827:0.005367:0.010357:0.009827:0.010175:0.004551:0.009827:0.009827:0.005367:0.009903:0.004747:0.005382:0.009223:0.008104:0.010311:0.009827:0.004551:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.003024:0.005866:0.014182:0.004188:0.004188
and the underlying disorder.:@0.076194:0.384544:0.282161:0.384544:0.282161:0.368761:0.076194:0.368761:0.010326:0.009223:0.010357:0.004188:0.005125:0.009223:0.009827:0.004188:0.009192:0.009223:0.010357:0.009827:0.004551:0.003024:0.008104:0.003024:0.009223:0.010175:0.004188:0.010357:0.003024:0.005866:0.009903:0.004551:0.010357:0.009827:0.004551:0.004188
Management  of  subclinical hyperthyroidism  is sum-:@0.090482:0.398814:0.480946:0.398814:0.480946:0.383031:0.090482:0.383031:0.013894:0.010326:0.009223:0.010326:0.010175:0.009827:0.014182:0.009827:0.009223:0.005125:0.004188:0.003523:0.009903:0.004747:0.004188:0.003523:0.005866:0.009192:0.010311:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.007726:0.009223:0.008104:0.010311:0.009827:0.004551:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.003024:0.005866:0.014182:0.004188:0.003523:0.003024:0.005866:0.007726:0.005866:0.009192:0.014182:0.005020
marised in Table 9.:@0.076194:0.413084:0.211631:0.413084:0.211631:0.397301:0.076194:0.397301:0.014182:0.010326:0.004551:0.003024:0.005866:0.009827:0.010357:0.004188:0.003024:0.009223:0.004188:0.006441:0.010326:0.010311:0.003024:0.009827:0.004188:0.008376:0.004188
tHyrOiD stOrm:@0.076190:0.446049:0.217738:0.446049:0.217738:0.425885:0.076190:0.425885:0.007761:0.012566:0.011457:0.010718:0.015522:0.005174:0.012935:0.005174:0.009609:0.007761:0.015522:0.010718:0.016631
A thyroid storm is a rare, but life-threatening complica-:@0.076190:0.462093:0.480942:0.462093:0.480942:0.446310:0.076190:0.446310:0.011188:0.004959:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.004959:0.005866:0.005125:0.009903:0.004551:0.014182:0.004959:0.003024:0.005866:0.004974:0.010326:0.004974:0.004551:0.010326:0.004551:0.009827:0.004188:0.004959:0.010311:0.009192:0.005125:0.004974:0.003024:0.003024:0.004747:0.009827:0.005020:0.005125:0.009223:0.004551:0.009827:0.010326:0.005125:0.009827:0.009223:0.003024:0.009223:0.010175:0.004959:0.009782:0.009903:0.014182:0.010311:0.003024:0.003024:0.009782:0.010326:0.005020
tion of severe thyrotoxicosis. It usually develops in pa-:@0.076190:0.476363:0.480942:0.476363:0.480942:0.460580:0.076190:0.460580:0.005125:0.003024:0.009903:0.009223:0.006380:0.009903:0.004747:0.006380:0.005866:0.009827:0.008376:0.009827:0.004551:0.009827:0.006380:0.005125:0.009223:0.008104:0.004551:0.009903:0.005125:0.009903:0.007257:0.003024:0.009782:0.009903:0.005866:0.003024:0.005866:0.004188:0.006365:0.003417:0.005125:0.006380:0.009192:0.005866:0.009192:0.010326:0.003024:0.003024:0.008104:0.006395:0.010357:0.009827:0.008376:0.009827:0.003024:0.009903:0.010311:0.005866:0.006380:0.003024:0.009223:0.006380:0.010311:0.010326:0.005020
tients with underlying, poorly treated Graves’ disease, :@0.076190:0.490633:0.485130:0.490633:0.485130:0.474850:0.076190:0.474850:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.006350:0.012564:0.003024:0.005125:0.009223:0.006350:0.009192:0.009223:0.010357:0.009827:0.004551:0.003024:0.008104:0.003024:0.009223:0.010175:0.004188:0.006350:0.010311:0.009903:0.009903:0.004551:0.003024:0.008104:0.006350:0.005125:0.004551:0.009827:0.010326:0.005125:0.009827:0.010357:0.006335:0.013184:0.004551:0.010326:0.008376:0.009827:0.005866:0.005307:0.006350:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.004188:0.004188
and is often  precipitated by a physiological stressful :@0.076190:0.504903:0.485115:0.504903:0.485115:0.489121:0.076190:0.489121:0.010326:0.009223:0.010357:0.008149:0.003024:0.005866:0.008149:0.009903:0.004747:0.005125:0.009827:0.009223:0.004188:0.003946:0.010311:0.004551:0.009827:0.009782:0.003024:0.010311:0.003024:0.005125:0.010326:0.005125:0.009827:0.010357:0.008149:0.010311:0.008104:0.008149:0.010326:0.008149:0.010311:0.009223:0.008104:0.005866:0.003024:0.009903:0.003024:0.009903:0.010175:0.003024:0.009782:0.010326:0.003024:0.008149:0.005866:0.005125:0.004551:0.009827:0.005866:0.005866:0.004747:0.009192:0.003024:0.004188
event, such as trauma, infection, surgery or discontinua-:@0.076190:0.519173:0.480957:0.519173:0.480957:0.503391:0.076190:0.503391:0.009827:0.008376:0.009827:0.009223:0.005125:0.004188:0.003598:0.005866:0.009192:0.009782:0.009223:0.003598:0.010326:0.005866:0.003613:0.005125:0.004551:0.010326:0.009192:0.014182:0.010326:0.004188:0.003598:0.003024:0.009223:0.004747:0.009827:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.003598:0.005866:0.009192:0.004551:0.010175:0.009827:0.004551:0.008104:0.003598:0.009903:0.004551:0.003598:0.010357:0.003024:0.005866:0.009782:0.009903:0.009223:0.005125:0.003024:0.009223:0.009192:0.010326:0.005020
tion of antithyroid drugs.  A thyroid storm is a medical :@0.076190:0.533444:0.485126:0.533420:0.485126:0.517637:0.076190:0.517661:0.005125:0.003024:0.009903:0.009223:0.005549:0.009903:0.004747:0.005549:0.010326:0.009223:0.005125:0.003024:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.005549:0.010357:0.004551:0.009192:0.010175:0.005866:0.004188:0.009717:0.005549:0.011188:0.005549:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.005549:0.005866:0.005125:0.009903:0.004551:0.014182:0.005549:0.003024:0.005866:0.005564:0.010326:0.005549:0.014182:0.009827:0.010357:0.003024:0.009782:0.010326:0.003024:0.150728
16:@0.257072:0.528121:0.266788:0.528121:0.266788:0.518967:0.257072:0.518967:0.004858:0.004858
emergency and requires early recognition and aggres-:@0.076186:0.547690:0.480938:0.547690:0.480938:0.531908:0.076186:0.531908:0.009827:0.014182:0.009827:0.004551:0.010175:0.009827:0.009223:0.009782:0.008104:0.004460:0.010326:0.009223:0.010357:0.004460:0.004551:0.009827:0.010311:0.009192:0.003024:0.004551:0.009827:0.005866:0.004460:0.009827:0.010326:0.004551:0.003024:0.008104:0.004475:0.004551:0.009827:0.009782:0.009903:0.010175:0.009223:0.003024:0.005125:0.003024:0.009903:0.009223:0.004445:0.010326:0.009223:0.010357:0.004460:0.010326:0.010175:0.010175:0.004551:0.009827:0.005866:0.005020
sive treatment. :@0.076186:0.561960:0.189155:0.561960:0.189155:0.546178:0.076186:0.546178:0.005866:0.003024:0.008376:0.009827:0.004188:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188:0.004188
The diagnosis of a thyroid storm is a clinical diagnosis. :@0.533325:0.084937:0.927992:0.084937:0.927992:0.069154:0.533325:0.069154:0.006441:0.009223:0.009827:0.004430:0.010357:0.003024:0.010326:0.010175:0.009223:0.009903:0.005866:0.003024:0.005866:0.004445:0.009903:0.004747:0.004430:0.010326:0.004445:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.004430:0.005866:0.005125:0.009903:0.004551:0.014182:0.004445:0.003024:0.005866:0.004445:0.010326:0.004445:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.004445:0.010357:0.003024:0.010326:0.010175:0.009223:0.009903:0.005866:0.003024:0.005866:0.004188:0.004188
patients  usually present  with  severely exaggerated :@0.519038:0.099507:0.927992:0.099507:0.927992:0.083725:0.519038:0.083725:0.008950:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188:0.007151:0.009192:0.005866:0.009192:0.010326:0.003024:0.003024:0.008104:0.011354:0.010311:0.004551:0.009827:0.005866:0.009827:0.009223:0.005125:0.004188:0.007151:0.012564:0.003024:0.005125:0.009223:0.004188:0.007151:0.005866:0.009827:0.008376:0.009827:0.004551:0.009827:0.003024:0.008104:0.011354:0.009827:0.007257:0.010326:0.010175:0.010175:0.009827:0.004551:0.010326:0.005125:0.009827:0.010357:0.004188
symptoms, typically seen  with thyrotoxicosis.  patients :@0.519038:0.114078:0.927992:0.114078:0.927992:0.098295:0.519038:0.098295:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.004188:0.008648:0.005125:0.008104:0.010311:0.003024:0.009782:0.010326:0.003024:0.003024:0.008104:0.008648:0.005866:0.009827:0.009827:0.009223:0.004188:0.004445:0.012564:0.003024:0.005125:0.009223:0.008648:0.005125:0.009223:0.008104:0.004551:0.009903:0.005125:0.009903:0.007257:0.003024:0.009782:0.009903:0.005866:0.003024:0.005866:0.004188:0.004188:0.004460:0.008950:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188
appear very agitated and often confused, and present :@0.519038:0.128394:0.927977:0.128394:0.927977:0.112611:0.519038:0.112611:0.010326:0.010311:0.010311:0.009827:0.010326:0.004551:0.003931:0.008376:0.009827:0.004551:0.008104:0.003931:0.010326:0.010175:0.003024:0.005125:0.010326:0.005125:0.009827:0.010357:0.003931:0.010326:0.009223:0.010357:0.003931:0.009903:0.004747:0.005125:0.009827:0.009223:0.003916:0.009782:0.009903:0.009223:0.004747:0.009192:0.005866:0.009827:0.010357:0.004188:0.003931:0.010326:0.009223:0.010357:0.003931:0.010311:0.004551:0.009827:0.005866:0.009827:0.009223:0.005125:0.004188
with  palpitations,  tachycardia,  hyperpyrexia  and  gas-:@0.519038:0.142710:0.923759:0.142710:0.923759:0.126928:0.519038:0.126928:0.012564:0.003024:0.005125:0.009223:0.004188:0.002449:0.010311:0.010326:0.003024:0.010311:0.003024:0.005125:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188:0.004188:0.002449:0.005125:0.010326:0.009782:0.009223:0.008104:0.009782:0.010326:0.004551:0.010357:0.003024:0.010326:0.004188:0.004188:0.002449:0.009223:0.008104:0.010311:0.009827:0.004551:0.010311:0.008104:0.004551:0.009827:0.007257:0.003024:0.010326:0.004188:0.002449:0.010326:0.009223:0.010357:0.004188:0.002449:0.010175:0.010326:0.005866:0.005020
tro-intestinal symptoms.  :@0.519038:0.157027:0.703251:0.157028:0.703251:0.141245:0.519038:0.141244:0.005125:0.004551:0.009903:0.005020:0.003024:0.009223:0.005125:0.009827:0.005866:0.005125:0.003024:0.009223:0.010326:0.003024:0.004188:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.004188:0.009724:0.425497
17:@0.689343:0.151730:0.699059:0.151730:0.699059:0.142576:0.689343:0.142576:0.004858:0.004858
Treatment is aimed at the suppression of synthesis and :@0.533328:0.171344:0.927980:0.171344:0.927980:0.155562:0.533328:0.155562:0.006441:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.003613:0.003024:0.005866:0.003629:0.010326:0.003024:0.014182:0.009827:0.010357:0.003629:0.010326:0.005125:0.003629:0.005125:0.009223:0.009827:0.003613:0.005866:0.009192:0.010311:0.010311:0.004551:0.009827:0.005866:0.005866:0.003024:0.009903:0.009223:0.003629:0.009903:0.004747:0.003613:0.005866:0.008104:0.009223:0.005125:0.009223:0.009827:0.005866:0.003024:0.005866:0.003629:0.010326:0.009223:0.010357:0.004188
release of thyroid hormones, symptomatic control of the :@0.519040:0.185661:0.927995:0.185661:0.927995:0.169878:0.519040:0.169878:0.004551:0.009827:0.003024:0.009827:0.010326:0.005866:0.009827:0.003356:0.009903:0.004747:0.003356:0.005125:0.009223:0.008104:0.004551:0.009888:0.003024:0.010357:0.003356:0.009223:0.009903:0.004551:0.014182:0.009903:0.009223:0.009827:0.005866:0.004188:0.003341:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.010326:0.005125:0.003024:0.009782:0.003356:0.009782:0.009903:0.009223:0.005125:0.004551:0.009903:0.003024:0.003341:0.009903:0.004747:0.003356:0.005125:0.009223:0.009827:0.004188
hyper-metabolic state and full supportive management :@0.519040:0.199977:0.927995:0.199977:0.927995:0.184195:0.519040:0.184195:0.009223:0.008104:0.010311:0.009827:0.004551:0.005020:0.014182:0.009827:0.005125:0.010326:0.010311:0.009903:0.003024:0.003024:0.009782:0.003432:0.005866:0.005125:0.010326:0.005125:0.009827:0.003432:0.010326:0.009223:0.010357:0.003432:0.004747:0.009192:0.003024:0.003024:0.003432:0.005866:0.009192:0.010311:0.010311:0.009903:0.004551:0.005125:0.003024:0.008376:0.009827:0.003432:0.014182:0.010326:0.009223:0.010326:0.010175:0.009827:0.014182:0.009827:0.009223:0.005125:0.004188
in an intensive-care unit.:@0.519040:0.214294:0.697173:0.214294:0.697173:0.198511:0.519040:0.198511:0.003024:0.009223:0.004188:0.010326:0.009223:0.004188:0.003024:0.009223:0.005125:0.009827:0.009223:0.005866:0.003024:0.008376:0.009827:0.005020:0.009782:0.010326:0.004551:0.009827:0.004188:0.009192:0.009223:0.003024:0.005125:0.004188
fOllOW-uP:@0.519047:0.247359:0.621790:0.247359:0.621790:0.227194:0.519047:0.227194:0.008870:0.015522:0.008131:0.008131:0.015522:0.016631:0.007761:0.011826:0.010348
The prognosis for a patient with hyperthyroidism is good :@0.519047:0.263454:0.927987:0.263454:0.927987:0.247671:0.519047:0.247671:0.006290:0.009071:0.009676:0.005065:0.010160:0.004400:0.009752:0.010024:0.009071:0.009752:0.005715:0.002873:0.005715:0.005065:0.004596:0.009752:0.004400:0.005065:0.010175:0.005065:0.010160:0.010175:0.004974:0.002873:0.009676:0.009071:0.004974:0.005065:0.012413:0.002873:0.004974:0.009071:0.005065:0.009071:0.007953:0.010160:0.009676:0.004400:0.004974:0.009071:0.007953:0.004400:0.009752:0.002873:0.010205:0.002873:0.005715:0.014030:0.005065:0.002873:0.005715:0.005065:0.010024:0.009752:0.009752:0.010357:0.004188
with appropriate therapy. For the first two years, closely :@0.519047:0.277770:0.928047:0.277770:0.928047:0.261988:0.519047:0.261988:0.012413:0.002873:0.004974:0.009071:0.005382:0.010175:0.010160:0.010160:0.004400:0.009752:0.010160:0.004400:0.002873:0.010175:0.004974:0.009676:0.005382:0.004974:0.009071:0.009676:0.004400:0.010175:0.010160:0.007953:0.004037:0.005382:0.007182:0.009752:0.004400:0.005382:0.004974:0.009071:0.009676:0.005382:0.003606:0.003606:0.004400:0.005715:0.004974:0.005382:0.004974:0.012413:0.009752:0.005382:0.007953:0.009676:0.010175:0.004400:0.005715:0.004037:0.005382:0.009631:0.002873:0.009752:0.005715:0.009676:0.002873:0.008104:0.004188
monitor the patient during any treatment at three-month-:@0.519047:0.292086:0.923814:0.292086:0.923814:0.276304:0.519047:0.276304:0.014030:0.009752:0.009071:0.002873:0.004974:0.009752:0.004400:0.002827:0.004974:0.009071:0.009676:0.002827:0.010160:0.010175:0.004974:0.002873:0.009676:0.009071:0.004974:0.002827:0.010205:0.009041:0.004400:0.002873:0.009071:0.010024:0.002827:0.010175:0.009071:0.007953:0.002827:0.004974:0.004400:0.009676:0.010175:0.004974:0.014030:0.009676:0.009071:0.004974:0.002827:0.010175:0.004974:0.002827:0.004974:0.009071:0.004400:0.009676:0.009676:0.004868:0.014030:0.009752:0.009071:0.004974:0.009071:0.005020
ly intervals. Thereafter, annual monitoring is recommend-:@0.519047:0.306403:0.923844:0.306403:0.923844:0.290620:0.519047:0.290620:0.002873:0.007953:0.003946:0.002873:0.009071:0.004974:0.009676:0.004400:0.008225:0.010175:0.002873:0.005715:0.004037:0.003946:0.006290:0.009071:0.009676:0.004400:0.009676:0.010175:0.004596:0.004974:0.009676:0.004400:0.004037:0.003946:0.010175:0.009071:0.009071:0.009041:0.010175:0.002873:0.003946:0.014030:0.009752:0.009071:0.002873:0.004974:0.009752:0.004400:0.002873:0.009071:0.010024:0.003946:0.002873:0.005715:0.003946:0.004400:0.009676:0.009631:0.009752:0.014030:0.014030:0.009676:0.009071:0.010205:0.005020
ed, even if the patient is asymptomatic. patient educa-:@0.519047:0.320719:0.923860:0.320719:0.923860:0.304937:0.519047:0.304937:0.009676:0.010205:0.004037:0.004974:0.009676:0.008225:0.009676:0.009071:0.004974:0.002873:0.004596:0.004974:0.004974:0.009071:0.009676:0.004974:0.010160:0.010175:0.004974:0.002873:0.009676:0.009071:0.004974:0.004974:0.002873:0.005715:0.004974:0.010175:0.005715:0.007953:0.014030:0.010160:0.004974:0.009752:0.014030:0.010175:0.004974:0.002873:0.009631:0.004037:0.004974:0.008799:0.010175:0.004974:0.002873:0.009676:0.009071:0.004974:0.004974:0.009676:0.010205:0.009041:0.009631:0.010175:0.005020
tion regarding the risk of relapse, as well as possible late :@0.519047:0.335036:0.927972:0.335036:0.927972:0.319253:0.519047:0.319253:0.004974:0.002873:0.009752:0.009071:0.004762:0.004400:0.009676:0.010024:0.010175:0.004400:0.010205:0.002873:0.009071:0.010024:0.004762:0.004974:0.009071:0.009676:0.004762:0.004400:0.002873:0.005715:0.007439:0.004762:0.009752:0.004596:0.004762:0.004400:0.009676:0.002873:0.010175:0.010160:0.005715:0.009676:0.004037:0.004762:0.010175:0.005715:0.004762:0.012413:0.009676:0.002873:0.002873:0.004762:0.010175:0.005715:0.004762:0.010160:0.009752:0.005715:0.005715:0.002873:0.010160:0.002873:0.009676:0.004762:0.002873:0.010175:0.004974:0.009827:0.004188
onset hypothyroidism, is of the utmost importance.:@0.519047:0.349352:0.879349:0.349352:0.879349:0.333569:0.519047:0.333569:0.009752:0.009071:0.005715:0.009676:0.004974:0.004037:0.009071:0.007953:0.010160:0.009752:0.004974:0.009071:0.007953:0.004400:0.009752:0.002873:0.010205:0.002873:0.005715:0.014030:0.004037:0.004037:0.002873:0.005715:0.004037:0.009752:0.004596:0.004037:0.004974:0.009071:0.009676:0.004037:0.009041:0.004974:0.014030:0.009752:0.005715:0.004974:0.004037:0.002873:0.014030:0.010160:0.009752:0.004400:0.004974:0.010175:0.009071:0.009631:0.009676:0.004188
referenCes:@0.519047:0.382418:0.625485:0.382418:0.625485:0.362253:0.519047:0.362253:0.010718:0.009609:0.008870:0.009609:0.010718:0.009609:0.013674:0.014413:0.009609:0.009609
1. :@0.519047:0.394518:0.532077:0.394518:0.532077:0.382243:0.519047:0.382243:0.006515:0.003257:0.003257
Fauci As, Braunwald E, Isselbacher KJ, Wilson JD, :@0.544247:0.394518:0.823424:0.394518:0.823424:0.382243:0.544247:0.382243:0.005703:0.008032:0.007150:0.007608:0.002352:0.003445:0.008702:0.005856:0.003257:0.003434:0.006750:0.003540:0.008032:0.007150:0.007173:0.009772:0.008032:0.002352:0.008055:0.003445:0.006303:0.003257:0.003434:0.002658:0.004563:0.004563:0.007644:0.002352:0.008020:0.008032:0.007608:0.007173:0.007644:0.003540:0.003434:0.006950:0.005668:0.003257:0.003434:0.011289:0.002352:0.002352:0.004563:0.007702:0.007173:0.003445:0.005668:0.008749:0.003257:0.003257
et al,:@0.823624:0.394518:0.852328:0.394518:0.852328:0.382243:0.823624:0.382243:0.007644:0.003986:0.003434:0.008032:0.002352:0.003257
 editors. Har-:@0.852328:0.394518:0.923812:0.394518:0.923812:0.382243:0.852328:0.382243:0.003445:0.007644:0.008055:0.002352:0.003986:0.007702:0.003540:0.004563:0.003257:0.003434:0.008032:0.008032:0.003540:0.003904
rison’s principles of Internal Medicine. New York: McGraw Hill; 2005. :@0.544247:0.405626:0.925400:0.405626:0.925400:0.393351:0.544247:0.393351:0.003540:0.002352:0.004563:0.007702:0.007173:0.004127:0.004563:0.003257:0.006961:0.003540:0.002352:0.007173:0.007608:0.002352:0.008020:0.002352:0.007644:0.004563:0.003257:0.007702:0.003692:0.003257:0.002658:0.007173:0.003986:0.007644:0.003540:0.007173:0.008032:0.002352:0.003257:0.010807:0.007644:0.008055:0.002352:0.007608:0.002352:0.007173:0.007644:0.003257:0.003257:0.008702:0.007644:0.009772:0.003257:0.006961:0.007702:0.003540:0.005903:0.003257:0.003257:0.010807:0.007608:0.010254:0.003540:0.008032:0.009772:0.003257:0.008032:0.002352:0.002352:0.002352:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257
2. :@0.519047:0.416734:0.532077:0.416734:0.532077:0.404459:0.519047:0.404459:0.006515:0.003257:0.003257
Ross sD. Treatment of Graves’ hyperthyroidism. Available at www.:@0.544247:0.416734:0.923812:0.416734:0.923812:0.404459:0.544247:0.404459:0.007138:0.007702:0.004563:0.004563:0.004010:0.005856:0.008749:0.003257:0.004010:0.005009:0.003540:0.007644:0.008032:0.003986:0.011030:0.007644:0.007173:0.003986:0.003998:0.007702:0.003692:0.003998:0.010254:0.003540:0.008032:0.006515:0.007644:0.004563:0.004127:0.004010:0.007173:0.006303:0.008020:0.007644:0.003540:0.003986:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.002352:0.004563:0.011030:0.003257:0.003998:0.008702:0.006515:0.008032:0.002352:0.002352:0.008032:0.008020:0.002352:0.007644:0.004010:0.008032:0.003986:0.004010:0.009772:0.009772:0.009772:0.003257
uptodateonline.com. Accessed March 2012. :@0.544247:0.427842:0.801951:0.427842:0.801951:0.415567:0.544247:0.415567:0.007150:0.008020:0.003986:0.007702:0.008055:0.008032:0.003986:0.007644:0.007702:0.007173:0.002352:0.002352:0.007173:0.007644:0.003257:0.007608:0.007702:0.011018:0.003257:0.003257:0.008702:0.007608:0.007608:0.007644:0.004563:0.004563:0.007644:0.008055:0.003257:0.010807:0.008032:0.003540:0.007608:0.007173:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257
3. :@0.519047:0.438950:0.532077:0.438950:0.532077:0.426675:0.519047:0.426675:0.006515:0.003257:0.003257
Weetman Ap. Graves’ disease. :@0.544247:0.438950:0.723776:0.438950:0.723776:0.426675:0.544247:0.426675:0.011289:0.007644:0.007644:0.003986:0.011030:0.008032:0.007173:0.003257:0.008702:0.006961:0.003257:0.003257:0.010254:0.003540:0.008032:0.006515:0.007644:0.004563:0.004127:0.003257:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.003257:0.003257
N Engl J Med. :@0.723764:0.438950:0.804668:0.438950:0.804668:0.426675:0.723764:0.426675:0.008702:0.003257:0.006303:0.007173:0.007914:0.002352:0.003257:0.005668:0.003257:0.010807:0.007644:0.008055:0.003257:0.003257
2000;343:1236-48.:@0.804656:0.438950:0.903022:0.438950:0.903022:0.426675:0.804656:0.426675:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
4. :@0.519047:0.450058:0.532077:0.450058:0.532077:0.437783:0.519047:0.437783:0.006515:0.003257:0.003257
Goldman L, Ausiello D, Arend  Wp, :@0.544247:0.450058:0.748270:0.450058:0.748270:0.437783:0.544247:0.437783:0.010254:0.007702:0.002352:0.008055:0.011030:0.008032:0.007173:0.005209:0.005433:0.003257:0.005209:0.008702:0.007150:0.004563:0.002352:0.007644:0.002352:0.002352:0.007702:0.005209:0.008749:0.003257:0.005209:0.008702:0.003540:0.007644:0.007173:0.008055:0.003257:0.001940:0.011289:0.006961:0.003257:0.003257
et al,:@0.750211:0.450058:0.780691:0.450058:0.780691:0.437783:0.750211:0.437783:0.007644:0.003986:0.005209:0.008032:0.002352:0.003257
 editors. :@0.780691:0.450058:0.830256:0.450058:0.830256:0.437783:0.780691:0.437783:0.005209:0.007644:0.008055:0.002352:0.003986:0.007702:0.003540:0.004563:0.003257:0.003257
Cecil Medicine. :@0.832196:0.450058:0.927070:0.450058:0.927070:0.437783:0.832196:0.437783:0.009560:0.007644:0.007608:0.002352:0.002352:0.005209:0.010807:0.007644:0.008055:0.002352:0.007608:0.002352:0.007173:0.007644:0.003257:0.003257
23rd Ed. philadelphia: saunders Elsevier; 2007.:@0.544247:0.461166:0.802022:0.461166:0.802022:0.448891:0.544247:0.448891:0.006515:0.006515:0.003540:0.008055:0.003257:0.006303:0.008055:0.003257:0.003257:0.006961:0.007173:0.002352:0.002352:0.008032:0.008055:0.007644:0.002352:0.008020:0.007173:0.002352:0.008032:0.003257:0.003257:0.005856:0.008032:0.007150:0.007173:0.008055:0.007644:0.003540:0.004563:0.003257:0.006303:0.002352:0.004563:0.007644:0.006515:0.002352:0.007644:0.003540:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257
5. :@0.519047:0.472274:0.532077:0.472274:0.532077:0.459999:0.519047:0.459999:0.006515:0.003257:0.003257
American  Academy of  Clinical Endocrinologists.  American  Asso-:@0.544247:0.472274:0.923801:0.472274:0.923801:0.459999:0.544247:0.459999:0.008702:0.011030:0.007644:0.003540:0.002352:0.007608:0.008032:0.007173:0.003257:0.002258:0.008702:0.007608:0.008032:0.008055:0.007644:0.011030:0.006303:0.005527:0.007702:0.003692:0.003257:0.002258:0.009560:0.002352:0.002352:0.007173:0.002352:0.007608:0.008032:0.002352:0.005527:0.006303:0.007173:0.008055:0.007702:0.007608:0.003540:0.002352:0.007173:0.007702:0.002352:0.007702:0.007914:0.002352:0.004563:0.003986:0.004563:0.003257:0.003257:0.002258:0.008702:0.011030:0.007644:0.003540:0.002352:0.007608:0.008032:0.007173:0.003257:0.002258:0.008702:0.004563:0.004563:0.007702:0.003904
ciation of  Clinical Endocrinologists  medical guidelines for  clinical :@0.544247:0.483382:0.927046:0.483382:0.927046:0.471107:0.544247:0.471107:0.007608:0.002352:0.008032:0.003986:0.002352:0.007702:0.007173:0.005303:0.007702:0.003692:0.003257:0.002034:0.009560:0.002352:0.002352:0.007173:0.002352:0.007608:0.008032:0.002352:0.005303:0.006303:0.007173:0.008055:0.007702:0.007608:0.003540:0.002352:0.007173:0.007702:0.002352:0.007702:0.007914:0.002352:0.004563:0.003986:0.004563:0.003257:0.002034:0.011030:0.007644:0.008055:0.002352:0.007608:0.008032:0.002352:0.005303:0.007914:0.007150:0.002352:0.008055:0.007644:0.002352:0.002352:0.007173:0.007644:0.004563:0.005303:0.003692:0.007702:0.003540:0.003257:0.002034:0.007608:0.002352:0.002352:0.007173:0.002352:0.007608:0.008032:0.002352:0.003257
practice for the evaluation and treatment of hyperthyroidism and :@0.544247:0.494490:0.927046:0.494490:0.927046:0.482215:0.544247:0.482215:0.008020:0.003540:0.008032:0.007608:0.003986:0.002352:0.007608:0.007644:0.003928:0.003692:0.007702:0.003540:0.003928:0.003986:0.007173:0.007644:0.003928:0.007644:0.006515:0.008032:0.002352:0.007150:0.008032:0.003986:0.002352:0.007702:0.007173:0.003928:0.008032:0.007173:0.008055:0.003928:0.003986:0.003540:0.007644:0.008032:0.003986:0.011018:0.007644:0.007173:0.003986:0.003928:0.007702:0.003692:0.003928:0.007173:0.006303:0.008020:0.007644:0.003540:0.003986:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.002352:0.004563:0.011030:0.003928:0.008032:0.007173:0.008055:0.003257
hypothyroidism. :@0.544247:0.505598:0.637016:0.505598:0.637016:0.493323:0.544247:0.493323:0.007173:0.006303:0.008020:0.007702:0.003986:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.002352:0.004563:0.011030:0.003257:0.003257
Endocr Pract.:@0.637016:0.505598:0.714039:0.505598:0.714039:0.493323:0.637016:0.493323:0.006303:0.007173:0.008055:0.007702:0.007608:0.003540:0.003257:0.006961:0.003540:0.008032:0.007608:0.003986:0.003257
 2002;8:457-69.:@0.714027:0.505598:0.796107:0.505598:0.796107:0.493323:0.714027:0.493323:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
6. :@0.519059:0.516706:0.532088:0.516706:0.532088:0.504431:0.519059:0.504431:0.006515:0.003257:0.003257
Motomura K, Brent GA. Mechanism of thyroid hormone action: Im-:@0.544259:0.516706:0.923801:0.516706:0.923801:0.504431:0.544259:0.504431:0.010807:0.007702:0.003986:0.007702:0.011030:0.007150:0.003540:0.008032:0.003504:0.006950:0.003257:0.003504:0.006750:0.003540:0.007644:0.007173:0.003986:0.003504:0.010254:0.008702:0.003257:0.003504:0.010807:0.007644:0.007608:0.007173:0.008032:0.007173:0.002352:0.004563:0.011030:0.003504:0.007702:0.003692:0.003504:0.003986:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.003504:0.007173:0.007702:0.003540:0.011030:0.007702:0.007173:0.007644:0.003492:0.008032:0.007608:0.003986:0.002352:0.007702:0.007173:0.003257:0.003504:0.002658:0.011030:0.003904
plications for the clinical manifestations of thyrotoxicosis. :@0.544259:0.527814:0.864299:0.527814:0.864299:0.515539:0.544259:0.515539:0.008020:0.002352:0.002352:0.007608:0.008032:0.003986:0.002352:0.007702:0.007173:0.004563:0.002834:0.003692:0.007702:0.003540:0.002822:0.003986:0.007173:0.007644:0.002822:0.007608:0.002352:0.002352:0.007173:0.002352:0.007608:0.008032:0.002352:0.002834:0.011030:0.008032:0.007173:0.002352:0.003692:0.007644:0.004563:0.003986:0.008032:0.003986:0.002352:0.007702:0.007173:0.004563:0.002834:0.007702:0.003692:0.002822:0.003986:0.007173:0.006303:0.003540:0.007702:0.003986:0.007702:0.005644:0.002352:0.007608:0.007702:0.004563:0.002352:0.004563:0.003257:0.003257
Endocrinol :@0.863864:0.527814:0.927082:0.527814:0.927082:0.515539:0.863864:0.515539:0.006303:0.007173:0.008055:0.007702:0.007608:0.003540:0.002352:0.007173:0.007702:0.002352:0.003257
Metab Clin North Am.:@0.544259:0.538922:0.668049:0.538922:0.668049:0.526647:0.544259:0.526647:0.010807:0.007644:0.003986:0.008032:0.008020:0.003257:0.009560:0.002352:0.002352:0.007173:0.003257:0.008702:0.007702:0.003540:0.003986:0.007173:0.003257:0.008702:0.011030:0.003257
 1998;27:1-23.:@0.668025:0.538922:0.743590:0.538922:0.743590:0.526647:0.668025:0.526647:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.003257:0.006515:0.003904:0.006515:0.006515:0.003257
7. :@0.519059:0.550030:0.532088:0.550030:0.532088:0.537755:0.519059:0.537755:0.006515:0.003257:0.003257
Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. :@0.544259:0.550030:0.927070:0.550030:0.927070:0.537755:0.544259:0.537755:0.006950:0.002352:0.007644:0.002352:0.007173:0.003187:0.002658:0.003257:0.003187:0.010219:0.002387:0.008032:0.011030:0.008032:0.008032:0.003187:0.006950:0.003257:0.003187:0.005009:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.003175:0.007173:0.007702:0.003540:0.011030:0.007702:0.007173:0.007644:0.003175:0.008032:0.007173:0.008055:0.003187:0.003986:0.007173:0.007644:0.003175:0.007608:0.008032:0.003540:0.008055:0.002352:0.007702:0.006515:0.008032:0.004563:0.007608:0.007150:0.002352:0.008032:0.003540:0.003187:0.004563:0.006303:0.004563:0.003986:0.007644:0.011030:0.003257:0.003257
N Engl J Med.:@0.544259:0.561138:0.621905:0.561138:0.621905:0.548863:0.544259:0.548863:0.008702:0.003257:0.006303:0.007173:0.007914:0.002352:0.003257:0.005668:0.003257:0.010807:0.007644:0.008055:0.003257
 2001;377(7):501-508.:@0.621894:0.561138:0.738710:0.561138:0.738710:0.548863:0.621894:0.548863:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257
table 9. management of subclinical hyperthyroidism:@0.077030:0.593004:0.460147:0.593004:0.460147:0.576505:0.077030:0.576505:0.006350:0.009979:0.009979:0.003629:0.009676:0.004233:0.008467:0.004233:0.004233:0.013607:0.009979:0.009071:0.009979:0.009979:0.009676:0.014212:0.009676:0.009071:0.004536:0.004233:0.009676:0.004233:0.004233:0.006652:0.009071:0.009979:0.009676:0.003629:0.003629:0.009071:0.003629:0.009676:0.009979:0.003629:0.004233:0.009071:0.008769:0.009979:0.009676:0.004838:0.004536:0.009071:0.008769:0.004838:0.009676:0.003629:0.009979:0.003629:0.006652:0.014212
14:@0.460130:0.587705:0.469951:0.587705:0.469951:0.578136:0.460130:0.578136:0.004911:0.004911
A.  Patients receiving t4 therapy :@0.112308:0.611852:0.332576:0.611852:0.332576:0.597187:0.112308:0.597187:0.009945:0.003763:0.003763:0.012767:0.007526:0.008870:0.004032:0.003225:0.008601:0.008063:0.004032:0.005913:0.003763:0.004301:0.008601:0.008601:0.008601:0.003225:0.007526:0.003225:0.008063:0.008870:0.003763:0.005644:0.007526:0.003763:0.004032:0.008063:0.008601:0.004301:0.008870:0.008870:0.007795:0.003763
Treatment is for hyperthyroidism and TsH :@0.082070:0.627246:0.346445:0.627246:0.346445:0.613217:0.082070:0.613217:0.005725:0.004045:0.008735:0.009179:0.004556:0.012606:0.008735:0.008198:0.004556:0.003723:0.002688:0.005214:0.003723:0.004220:0.008803:0.004045:0.003723:0.008198:0.007203:0.009165:0.008735:0.004045:0.004556:0.008198:0.007203:0.004045:0.008803:0.002688:0.009206:0.002688:0.005214:0.012606:0.003723:0.009179:0.008198:0.009206:0.003723:0.005725:0.006693:0.009179:0.003723
levels below normal:@0.082070:0.640075:0.211099:0.640075:0.211099:0.626046:0.082070:0.626046:0.002688:0.008735:0.007445:0.008735:0.002688:0.005214:0.003723:0.009165:0.008735:0.002688:0.008803:0.011168:0.003723:0.008198:0.008803:0.004045:0.012606:0.009179:0.002688
Adjust T4 dose to maintain TsH concentration within the normal reference range:@0.365045:0.627246:0.884387:0.627246:0.884387:0.613217:0.365045:0.613217:0.009945:0.009206:0.002728:0.008171:0.005214:0.004556:0.003723:0.005725:0.007445:0.003723:0.009206:0.008803:0.005214:0.008735:0.003723:0.004556:0.008803:0.003723:0.012606:0.009179:0.002688:0.008198:0.004556:0.009179:0.002688:0.008198:0.003723:0.005725:0.006693:0.009179:0.003723:0.008695:0.008803:0.008198:0.008695:0.008735:0.008198:0.004556:0.004045:0.009179:0.004556:0.002688:0.008803:0.008198:0.003723:0.011168:0.002688:0.004556:0.008198:0.002688:0.008198:0.003723:0.004556:0.008198:0.008735:0.003723:0.008198:0.008803:0.004045:0.012606:0.009179:0.002688:0.003723:0.004045:0.008735:0.004220:0.008735:0.004045:0.008735:0.008198:0.008695:0.008735:0.003723:0.004045:0.009179:0.008198:0.009045:0.008735
patient is on suppressive T4 treatment::@0.082070:0.655468:0.327308:0.655468:0.327308:0.641439:0.082070:0.641439:0.007956:0.009179:0.004556:0.002688:0.008735:0.008198:0.004556:0.003723:0.002688:0.005214:0.003723:0.008803:0.008198:0.003723:0.005214:0.008171:0.009165:0.009165:0.004045:0.008735:0.005214:0.005214:0.002688:0.007445:0.008735:0.003723:0.005725:0.007445:0.003723:0.004556:0.004045:0.008735:0.009179:0.004556:0.012606:0.008735:0.008198:0.004556:0.003723
• :@0.112308:0.667404:0.121850:0.667404:0.121850:0.654832:0.112308:0.654832:0.006182:0.003360
To reduce goitre growth:@0.142546:0.668297:0.299515:0.668297:0.299515:0.654268:0.142546:0.654268:0.005725:0.008803:0.003723:0.004045:0.008735:0.009206:0.008171:0.008695:0.008735:0.003723:0.009045:0.008803:0.002688:0.004556:0.004045:0.008735:0.003723:0.009045:0.004045:0.008803:0.011168:0.004556:0.008198
• :@0.112308:0.680232:0.121850:0.680232:0.121850:0.667660:0.112308:0.667660:0.006182:0.003360
To prevent recurrence of thyroid  suppressive therapy outweigh risks:@0.142546:0.681125:0.586360:0.681125:0.586360:0.667096:0.142546:0.667096:0.005725:0.008803:0.003723:0.009165:0.004045:0.008735:0.007445:0.008735:0.008198:0.004556:0.003723:0.004045:0.008735:0.008695:0.008171:0.004045:0.004045:0.008735:0.008198:0.008695:0.008735:0.003723:0.008803:0.004220:0.003723:0.004556:0.008198:0.007203:0.004045:0.008803:0.002688:0.009206:0.003723:0.008655:0.005214:0.008171:0.009165:0.009165:0.004045:0.008735:0.005214:0.005214:0.002688:0.007445:0.008735:0.003723:0.004556:0.008198:0.008735:0.004045:0.009179:0.009165:0.007203:0.003723:0.008803:0.008171:0.004556:0.011168:0.008735:0.002688:0.009045:0.008198:0.003723:0.004045:0.002688:0.005214:0.006746:0.005214
cancer:@0.142546:0.693953:0.190094:0.693953:0.190094:0.679924:0.142546:0.679924:0.008695:0.009179:0.008198:0.008695:0.008735:0.004045
subclinical hyperthyroidism is unavoidable:@0.365045:0.655468:0.639674:0.655468:0.639674:0.641439:0.365045:0.641439:0.006693:0.008171:0.009165:0.008695:0.002688:0.002688:0.008198:0.002688:0.008695:0.009179:0.002688:0.003723:0.008198:0.007203:0.009165:0.008735:0.004045:0.004556:0.008198:0.007203:0.004045:0.008803:0.002688:0.009206:0.002688:0.005214:0.012606:0.003723:0.002688:0.005214:0.003723:0.008171:0.008198:0.009179:0.007445:0.008803:0.002688:0.009206:0.009179:0.009165:0.002688:0.008735
Treat with lowest dose of T4 possible to still meet desired goal, as benefits of :@0.365045:0.668297:0.856380:0.668297:0.856380:0.654268:0.365045:0.654268:0.005725:0.004045:0.008735:0.009179:0.004556:0.003723:0.011168:0.002688:0.004556:0.008198:0.003723:0.002688:0.008803:0.011168:0.008735:0.005214:0.004556:0.003723:0.009206:0.008803:0.005214:0.008735:0.003723:0.008803:0.004220:0.003723:0.005725:0.007445:0.003723:0.009165:0.008803:0.005214:0.005214:0.002688:0.009165:0.002688:0.008735:0.003723:0.004556:0.008803:0.003723:0.005214:0.004556:0.002688:0.002688:0.002688:0.003723:0.012606:0.008735:0.008735:0.004556:0.003723:0.009206:0.008735:0.005214:0.002688:0.004045:0.008735:0.009206:0.003723:0.009045:0.008803:0.009179:0.002688:0.003723:0.003723:0.009179:0.005214:0.003723:0.009165:0.008735:0.008198:0.008735:0.003272:0.003272:0.004556:0.005214:0.003723:0.008803:0.004220:0.003723
b. :@0.112308:0.709347:0.127629:0.709347:0.127629:0.694682:0.112308:0.694682:0.007795:0.003763:0.003763
Patients with endogenous subclinical hyperthyroidism and at high risk of skeletal or cardiac complications::@0.142546:0.709347:0.835468:0.709347:0.835468:0.694682:0.142546:0.694682:0.007526:0.008870:0.004032:0.003225:0.008601:0.008063:0.004032:0.005913:0.003763:0.010751:0.003225:0.004032:0.008063:0.003763:0.008601:0.008063:0.008870:0.008601:0.008870:0.008601:0.008063:0.008601:0.008063:0.005913:0.003763:0.005913:0.008063:0.008870:0.008601:0.003225:0.003225:0.008063:0.003225:0.008601:0.008870:0.003225:0.003763:0.008063:0.007795:0.008870:0.008601:0.004301:0.004032:0.008063:0.007795:0.004301:0.008601:0.003225:0.008870:0.003225:0.005913:0.012633:0.003763:0.008870:0.008063:0.008870:0.003763:0.008870:0.004032:0.003763:0.008063:0.003225:0.008870:0.008063:0.003763:0.004301:0.003225:0.005913:0.007795:0.003763:0.008601:0.003763:0.003763:0.005913:0.007795:0.008601:0.003225:0.008601:0.004032:0.008870:0.003225:0.003763:0.008601:0.004301:0.003763:0.008601:0.008870:0.004301:0.008870:0.003225:0.008870:0.008601:0.003763:0.008601:0.008601:0.012633:0.008870:0.003225:0.003225:0.008601:0.008870:0.004032:0.003225:0.008601:0.008063:0.005913:0.003763
• :@0.142546:0.721283:0.152088:0.721283:0.152088:0.708711:0.142546:0.708711:0.006182:0.003360
Age >65:@0.172784:0.722175:0.227267:0.722175:0.227267:0.708146:0.172784:0.708146:0.009945:0.009045:0.008735:0.003723:0.008144:0.007445:0.007445
• :@0.142546:0.734111:0.152088:0.734111:0.152088:0.721539:0.142546:0.721539:0.006182:0.003360
Other risk factors for arrhythmias:@0.172784:0.735004:0.380473:0.735004:0.380473:0.720975:0.172784:0.720975:0.011679:0.004556:0.008198:0.008735:0.004045:0.003723:0.004045:0.002688:0.005214:0.006746:0.003723:0.004220:0.009179:0.008695:0.004556:0.008803:0.004045:0.005214:0.003723:0.004220:0.008803:0.004045:0.003723:0.009179:0.004045:0.004045:0.008198:0.007203:0.004556:0.008198:0.012606:0.002688:0.009179:0.005214
• :@0.142546:0.746939:0.152088:0.746939:0.152088:0.734367:0.142546:0.734367:0.006182:0.003360
postmenopausal women with or at risk of osteoporosis:@0.172784:0.747832:0.521772:0.747832:0.521772:0.733803:0.172784:0.733803:0.007956:0.008803:0.005214:0.004556:0.012606:0.008735:0.008198:0.008803:0.009165:0.009179:0.008171:0.005214:0.009179:0.002688:0.003723:0.011168:0.008803:0.012606:0.008735:0.008198:0.003723:0.011168:0.002688:0.004556:0.008198:0.003723:0.008803:0.004045:0.003723:0.009179:0.004556:0.003723:0.004045:0.002688:0.005214:0.006746:0.003723:0.008803:0.004220:0.003723:0.008803:0.005214:0.004556:0.008735:0.008803:0.009165:0.008803:0.004045:0.008803:0.005214:0.002688:0.005214
If serum TSH <0.1mU/ml:@0.082070:0.763226:0.230196:0.763226:0.230196:0.749197:0.082070:0.749197:0.003037:0.004220:0.003723:0.005214:0.008735:0.004045:0.008171:0.012606:0.003723:0.005725:0.006693:0.009179:0.003723:0.008144:0.007445:0.003723:0.007445:0.012606:0.008803:0.005873:0.012606:0.002688
Treat underlying cause of hyperthyroidism:@0.365045:0.763226:0.635924:0.763226:0.635924:0.749197:0.365045:0.749197:0.005725:0.004045:0.008735:0.009179:0.004556:0.003723:0.008171:0.008198:0.009206:0.008735:0.004045:0.002688:0.007203:0.002688:0.008198:0.009045:0.003723:0.008695:0.009179:0.008171:0.005214:0.008735:0.003723:0.008803:0.004220:0.003723:0.008198:0.007203:0.009165:0.008735:0.004045:0.004556:0.008198:0.007203:0.004045:0.008803:0.002688:0.009206:0.002688:0.005214:0.012606
If serum TsH 0.1-0.5mU/ml:@0.082070:0.778620:0.245127:0.778620:0.245127:0.764591:0.082070:0.764591:0.003037:0.004220:0.003723:0.005214:0.008735:0.004045:0.008171:0.012606:0.003723:0.005725:0.006693:0.009179:0.003723:0.007445:0.003723:0.007445:0.004462:0.007445:0.003723:0.007445:0.012606:0.008803:0.005873:0.012606:0.002688
Treat underlying cause of hyperthyroidism if::@0.365045:0.778620:0.650277:0.778620:0.650277:0.764591:0.365045:0.764591:0.005725:0.004045:0.008735:0.009179:0.004556:0.003723:0.008171:0.008198:0.009206:0.008735:0.004045:0.002688:0.007203:0.002688:0.008198:0.009045:0.003723:0.008695:0.009179:0.008171:0.005214:0.008735:0.003723:0.008803:0.004220:0.003723:0.008198:0.007203:0.009165:0.008735:0.004045:0.004556:0.008198:0.007203:0.004045:0.008803:0.002688:0.009206:0.002688:0.005214:0.012606:0.003723:0.002688:0.004220:0.003723
• :@0.399059:0.790555:0.408601:0.790555:0.408601:0.777984:0.399059:0.777984:0.006182:0.003360
There is underlying cardiovascular disease or if bone-mineral density is low:@0.429297:0.791448:0.907865:0.791448:0.907865:0.777419:0.429297:0.777419:0.005725:0.008198:0.008735:0.004045:0.008735:0.003723:0.002688:0.005214:0.003723:0.008171:0.008198:0.009206:0.008735:0.004045:0.002688:0.007203:0.002688:0.008198:0.009045:0.003723:0.008695:0.009179:0.004045:0.009206:0.002688:0.008803:0.007445:0.009179:0.005214:0.008695:0.008171:0.002688:0.009179:0.004045:0.003723:0.009206:0.002688:0.005214:0.008735:0.009179:0.005214:0.008735:0.003723:0.008803:0.004045:0.003723:0.002688:0.004220:0.003723:0.009165:0.008803:0.008198:0.008735:0.004462:0.012606:0.002688:0.008198:0.008735:0.004045:0.009179:0.002688:0.003723:0.009206:0.008735:0.008198:0.005214:0.002688:0.004556:0.007203:0.003723:0.002688:0.005214:0.003723:0.002688:0.008803:0.011168
or :@0.429297:0.804276:0.445868:0.804276:0.445868:0.790247:0.429297:0.790247:0.008803:0.004045:0.003723
• :@0.399059:0.816212:0.408601:0.816212:0.408601:0.803640:0.399059:0.803640:0.006182:0.003360
If radionuclide scan shows areas of increased uptake:@0.429297:0.817105:0.775422:0.817105:0.775422:0.803076:0.429297:0.803076:0.003037:0.004220:0.003723:0.004045:0.009179:0.009206:0.002688:0.008803:0.008198:0.008171:0.008695:0.002688:0.002688:0.009206:0.008735:0.003723:0.005214:0.008695:0.009179:0.008198:0.003723:0.005214:0.008198:0.008803:0.011168:0.005214:0.003723:0.009179:0.004045:0.008735:0.009179:0.005214:0.003723:0.008803:0.004220:0.003723:0.002688:0.008198:0.008695:0.004045:0.008735:0.009179:0.005214:0.008735:0.009206:0.003723:0.008171:0.009165:0.004556:0.009179:0.006746:0.008735
If none of the above:@0.365045:0.829933:0.498966:0.829933:0.498966:0.815904:0.365045:0.815904:0.003037:0.004220:0.003723:0.008198:0.008803:0.008198:0.008735:0.003723:0.008803:0.004220:0.003723:0.004556:0.008198:0.008735:0.003723:0.009179:0.009165:0.008803:0.007445:0.008735
• :@0.399059:0.841868:0.408601:0.841868:0.408601:0.829297:0.399059:0.829297:0.006182:0.003360
Observe patient, review TFT 6-monthly:@0.429297:0.842761:0.674951:0.842761:0.674951:0.828732:0.429297:0.828732:0.011679:0.009165:0.005214:0.008735:0.004045:0.007445:0.008735:0.003723:0.009165:0.009179:0.004556:0.002688:0.008735:0.008198:0.004556:0.003723:0.003723:0.004045:0.008735:0.007445:0.002688:0.008735:0.011168:0.003723:0.005725:0.006518:0.005725:0.003723:0.007445:0.004462:0.012606:0.008803:0.008198:0.004556:0.008198:0.002688:0.007203
Patients with endogenous subclinical hyperthyroidism and at low risk of complications::@0.082070:0.858155:0.643557:0.858155:0.643557:0.843490:0.082070:0.843490:0.007526:0.008870:0.004032:0.003225:0.008601:0.008063:0.004032:0.005913:0.003763:0.010751:0.003225:0.004032:0.008063:0.003763:0.008601:0.008063:0.008870:0.008601:0.008870:0.008601:0.008063:0.008601:0.008063:0.005913:0.003763:0.005913:0.008063:0.008870:0.008601:0.003225:0.003225:0.008063:0.003225:0.008601:0.008870:0.003225:0.003763:0.008063:0.007795:0.008870:0.008601:0.004301:0.004032:0.008063:0.007795:0.004301:0.008601:0.003225:0.008870:0.003225:0.005913:0.012633:0.003763:0.008870:0.008063:0.008870:0.003763:0.008870:0.004032:0.003763:0.003225:0.008601:0.010751:0.003763:0.004301:0.003225:0.005913:0.007795:0.003763:0.008601:0.003763:0.003763:0.008601:0.008601:0.012633:0.008870:0.003225:0.003225:0.008601:0.008870:0.004032:0.003225:0.008601:0.008063:0.005913:0.003763
• :@0.112308:0.870091:0.121850:0.870091:0.121850:0.857519:0.112308:0.857519:0.006182:0.003360
Young individuals:@0.142546:0.870983:0.255811:0.870983:0.255811:0.856954:0.142546:0.856954:0.007956:0.008803:0.008171:0.008198:0.009045:0.003723:0.002688:0.008198:0.009206:0.002688:0.007445:0.002688:0.009206:0.008171:0.009179:0.002688:0.005214
• :@0.112308:0.882919:0.121850:0.882919:0.121850:0.870347:0.112308:0.870347:0.006182:0.003360
premenopausal women:@0.142546:0.883812:0.298454:0.883812:0.298454:0.869783:0.142546:0.869783:0.007956:0.004045:0.008735:0.012606:0.008735:0.008198:0.008803:0.009165:0.009179:0.008171:0.005214:0.009179:0.002688:0.003723:0.011168:0.008803:0.012606:0.008735:0.008198
If serum TSH <0.1mU/ml:@0.082070:0.899206:0.230196:0.899206:0.230196:0.885177:0.082070:0.885177:0.003037:0.004220:0.003723:0.005214:0.008735:0.004045:0.008171:0.012606:0.003723:0.005725:0.006693:0.009179:0.003723:0.008144:0.007445:0.003723:0.007445:0.012606:0.008803:0.005873:0.012606:0.002688
Treat underlying cause of hyperthyroidism if patient has symptoms of hyperthyroidism :@0.365045:0.899206:0.919503:0.899206:0.919503:0.885177:0.365045:0.885177:0.005725:0.004045:0.008735:0.009179:0.004556:0.003723:0.008171:0.008198:0.009206:0.008735:0.004045:0.002688:0.007203:0.002688:0.008198:0.009045:0.003723:0.008695:0.009179:0.008171:0.005214:0.008735:0.003723:0.008803:0.004220:0.003723:0.008198:0.007203:0.009165:0.008735:0.004045:0.004556:0.008198:0.007203:0.004045:0.008803:0.002688:0.009206:0.002688:0.005214:0.012606:0.003723:0.002688:0.004220:0.003723:0.009165:0.009179:0.004556:0.002688:0.008735:0.008198:0.004556:0.003723:0.008198:0.009179:0.005214:0.003723:0.005214:0.007203:0.012606:0.009165:0.004556:0.008803:0.012606:0.005214:0.003723:0.008803:0.004220:0.003723:0.008198:0.007203:0.009165:0.008735:0.004045:0.004556:0.008198:0.007203:0.004045:0.008803:0.002688:0.009206:0.002688:0.005214:0.012606:0.003723
or if radionuclide scan shows areas of increased uptake:@0.365045:0.912034:0.727391:0.912034:0.727391:0.898005:0.365045:0.898005:0.008803:0.004045:0.003723:0.002688:0.004220:0.003723:0.004045:0.009179:0.009206:0.002688:0.008803:0.008198:0.008171:0.008695:0.002688:0.002688:0.009206:0.008735:0.003723:0.005214:0.008695:0.009179:0.008198:0.003723:0.005214:0.008198:0.008803:0.011168:0.005214:0.003723:0.009179:0.004045:0.008735:0.009179:0.005214:0.003723:0.008803:0.004220:0.003723:0.002688:0.008198:0.008695:0.004045:0.008735:0.009179:0.005214:0.008735:0.009206:0.003723:0.008171:0.009165:0.004556:0.009179:0.006746:0.008735
If serum TsH 0.1-0.5mU/ml:@0.082070:0.927428:0.245127:0.927428:0.245127:0.913399:0.082070:0.913399:0.003037:0.004220:0.003723:0.005214:0.008735:0.004045:0.008171:0.012606:0.003723:0.005725:0.006693:0.009179:0.003723:0.007445:0.003723:0.007445:0.004462:0.007445:0.003723:0.007445:0.012606:0.008803:0.005873:0.012606:0.002688
Observation alone, review TFT 6-monthly:@0.365045:0.927428:0.625912:0.927428:0.625912:0.913399:0.365045:0.913399:0.011679:0.009165:0.005214:0.008735:0.004045:0.007445:0.009179:0.004556:0.002688:0.008803:0.008198:0.003723:0.009179:0.002688:0.008803:0.008198:0.008735:0.003723:0.003723:0.004045:0.008735:0.007445:0.002688:0.008735:0.011168:0.003723:0.005725:0.006518:0.005725:0.003723:0.007445:0.004462:0.012606:0.008803:0.008198:0.004556:0.008198:0.002688:0.007203
TsH – thyroid-stimulating hormone; TFT – thyroid function test; T4 – thyroxine.:@0.082070:0.941466:0.504968:0.941466:0.504968:0.929190:0.082070:0.929190:0.005009:0.005856:0.008032:0.003257:0.005880:0.003257:0.003986:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.003904:0.004563:0.003986:0.002352:0.011030:0.007150:0.002352:0.008032:0.003986:0.002352:0.007173:0.007914:0.003257:0.007173:0.007702:0.003540:0.011030:0.007702:0.007173:0.007644:0.003257:0.003257:0.005009:0.005703:0.005009:0.003257:0.005880:0.003257:0.003986:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.003257:0.003692:0.007150:0.007173:0.007608:0.003986:0.002352:0.007702:0.007173:0.003257:0.003986:0.007644:0.004563:0.003986:0.003257:0.003257:0.005009:0.006515:0.003257:0.005880:0.003257:0.003986:0.007173:0.006303:0.003540:0.007702:0.005644:0.002352:0.007173:0.007644:0.003257